The Latest Headlines at American Banking and Market News
Rush Street Interactive, Inc. (NYSE:RSI) Given Average Rating of “Moderate Buy” by Brokerages
Rush Street Interactive, Inc. (NYSE:RSI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the six analysts that are currently covering the company, MarketBeat reports. Two equities... More of this article »
Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Consensus Rating of “Buy” from Analysts
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has been assigned a consensus rating of “Buy” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Eight equities... More of this article »
Paymentus Holdings, Inc. (NYSE:PAY) Given Consensus Recommendation of “Hold” by Brokerages
Paymentus Holdings, Inc. (NYSE:PAY – Get Free Report) has earned an average recommendation of “Hold” from the eight ratings firms that are currently covering the stock, Marketbeat reports. Seven analysts have rated... More of this article »
Azul S.A. (NYSE:AZUL) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Azul S.A. (NYSE:AZUL – Get Free Report) have received a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat.com reports. One investment analyst ... More of this article »
Trinity Capital Inc. (NASDAQ:TRIN) Given Average Rating of “Moderate Buy” by Brokerages
Trinity Capital Inc. (NASDAQ:TRIN – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. One analyst... More of this article »
DURECT Co. (NASDAQ:DRRX) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five ratings firms that are currently covering the stock, MarketBeat reports. Two research analysts have... More of this article »
ConvaTec Group PLC (LON:CTEC) Receives Average Rating of “Buy” from Brokerages
Shares of ConvaTec Group PLC (LON:CTEC – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are presently covering the stock, Marketbeat reports. Six research analysts have... More of this article »
Generation Bio Co. (NASDAQ:GBIO) Receives Average Rating of “Hold” from Analysts
Generation Bio Co. (NASDAQ:GBIO – Get Free Report) has been given a consensus recommendation of “Hold” by the six research firms that are currently covering the stock, MarketBeat reports. Four research analysts have... More of this article »
MAG Silver (NYSEAMERICAN:MAG) Shares Up 4% Following Analyst Upgrade
Shares of MAG Silver Corp. (NYSEAMERICAN:MAG – Get Free Report) rose 4% during mid-day trading on Thursday after HC Wainwright raised their price target on the stock from $16.00 to $17.00. HC Wainwright currently has a buy rating... More of this article »
Planet Labs PBC (NYSE:PL) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Planet Labs PBC (NYSE:PL – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, Marketbeat reports. One equities research analyst... More of this article »
Centessa Pharmaceuticals plc (NASDAQ:CNTA) Given Consensus Recommendation of “Moderate Buy” by Analysts
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the company, Marketbeat Ratings reports.... More of this article »
Hudbay Minerals (TSE:HBM) Hits New 52-Week High on Analyst Upgrade
Shares of Hudbay Minerals Inc. (TSE:HBM – Get Free Report) (NYSE:HBM) hit a new 52-week high on Thursday after Raymond James raised their price target on the stock from C$11.50 to C$14.00. The stock traded as high as C$11.20... More of this article »
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have been given a consensus rating of “Buy” by the five research firms that are covering the firm, MarketBeat reports. Five research... More of this article »